Qube Research & Technologies (QRT)’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.5M Sell
51,000
-28,900
-36% -$14.6M 0.03% 794
2025
Q4
$45.3M Buy
79,900
+13,000
+19% +$6.92M 0.05% 542
2025
Q3
$29.9M Buy
66,900
+3,000
+5% +$1.44M 0.03% 687
2025
Q2
$34.7M Buy
63,900
+57,100
+840% +$29.9M 0.04% 610
2025
Q1
$3.37M Sell
6,800
-19,300
-74% -$10.7M ﹤0.01% 1734
2024
Q4
$13.6M Buy
26,100
+4,100
+19% +$2.14M 0.02% 912
2024
Q3
$10.8M Buy
22,000
+21,900
+21,900% +$10.2M 0.02% 996
2024
Q2
$44.5K Sell
100
-1,000
-91% -$398K ﹤0.01% 2766
2024
Q1
$439K Sell
1,100
-12,600
-92% -$4.76M ﹤0.01% 2605
2023
Q4
$4.62M Sell
13,700
-5,000
-27% -$1.49M 0.01% 1074
2023
Q3
$5.47M Buy
+18,700
New +$5.84M 0.01% 896

Other funds holding ISRG

Qube Research & Technologies (QRT)'s ISRG Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Intuitive Surgical (ISRG) stake by 120% in Q1 2026, buying an estimated $81.5M and bringing the position to 294,903 shares worth $136M. The position accounts for 0.15% of the portfolio, ranked #150.

Qube Research & Technologies (QRT) first reported a position in ISRG in Q1 2018 and has held it in 19 quarters since. The position peaked at $346M in Q3 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Qube Research & Technologies (QRT) held 294,903 shares of Intuitive Surgical worth $136M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 161,015 Intuitive Surgical shares in Q1 2026, an estimated $81.5M.
  • Intuitive Surgical made up 0.15% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #150 holding.
  • Qube Research & Technologies (QRT) first reported a position in Intuitive Surgical in Q1 2018 and has held it in 19 quarters since.
  • Qube Research & Technologies (QRT)'s Intuitive Surgical position peaked at $346M in Q3 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.